{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:32:09Z","timestamp":1769311929593,"version":"3.49.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T00:00:00Z","timestamp":1515283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jfma.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T19:40:29Z","timestamp":1520019629000},"page":"72-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"P1","title":["Targeted treatment of primary aldosteronism \u2013 The consensus of Taiwan Society of Aldosteronism"],"prefix":"10.1016","volume":"118","author":[{"given":"Kuo-How","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0121-4866","authenticated-orcid":false,"given":"Chin-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Kai","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4129-0879","authenticated-orcid":false,"given":"Shih-Cheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Chou","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chieh","family":"Jeff Chueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Hsiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che-Hsiung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leay Kiaw","family":"Er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Li","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Chou","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Luwn","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Chang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kao-Lang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo-Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-How","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chieh","family":"Jeff Chueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Cheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoh-Fang","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan-Dun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/HJH.0b013e3282f3b352","article-title":"Evidence for improved control of hypertension in Taiwan: 1993\u20132002","volume":"26","author":"Su","year":"2008","journal-title":"J Hypertens"},{"issue":"10","key":"10.1016\/j.jfma.2018.01.006_bib2","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2967\/jnumed.109.064873","article-title":"131I-6\u03b2-iodomethyl-19-norcholesterol SPECT\/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results","volume":"50","author":"Yen","year":"2009","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.jfma.2018.01.006_bib3","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jfma.2018.01.006_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism \u2013 The Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.jfma.2018.01.006_bib5","first-page":"5","article-title":"Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2018.01.006_bib6","doi-asserted-by":"crossref","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long term outcome of Aldosteronism after target treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.jfma.2018.01.006_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","article-title":"Case detection and diagnosis of primary aldosteronism \u2013 the consensus of Taiwan Society of Aldosteronism","volume":"116","author":"Wu","year":"2017","journal-title":"J Formos Med Assoc = Taiwan yi zhi"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.surg.2012.05.042","article-title":"Meta-analysis of trials comparing laparoscopic transperitoneal and retroperitoneal adrenalectomy","volume":"153","author":"Nigri","year":"2013","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.ju.0000165336.44836.2d","article-title":"Prospective, randomized comparison of transperitoneal versus retroperitoneal laparoscopic adrenalectomy","volume":"174","author":"Rubinstein","year":"2005","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.jfma.2018.01.006_bib11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.eururo.2014.04.003","article-title":"Robot-assisted laparoscopic adrenalectomy: step-by-step technique and comparative outcomes","volume":"66","author":"Brandao","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.eururo.2007.12.028","article-title":"Laparoscopic adrenalectomy using needlescopic instruments for adrenal tumors less than 5 cm in 112 cases","volume":"54","author":"Liao","year":"2008","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.urology.2014.04.040","article-title":"Mini-retroperitoneoscopic adrenalectomy: our experience after 50 procedures","volume":"84","author":"Porpiglia","year":"2014","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0090-4295(98)00185-X","article-title":"Needlescopic adrenalectomy\u2014the initial series: comparison with conventional laparoscopic adrenalectomy","volume":"52","author":"Gill","year":"1998","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-5347(05)65378-5","article-title":"Clipless laparoscopic adrenalectomy with needlescopic instruments","volume":"167","author":"Chueh","year":"2002","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib16","first-page":"2590","article-title":"Laparoendoscopic single-site adrenalectomy versus conventional laparoscopic adrenalectomy: an updated meta analysis","volume":"13","author":"Wu","year":"2016","journal-title":"Urol J"},{"key":"10.1016\/j.jfma.2018.01.006_bib17","first-page":"2016","article-title":"Is laparoendoscopic single-site adrenalectomy a feasible alternative in treating aldosterone-producing adenoma?","author":"Wu","year":"2016","journal-title":"BioMed Res Int"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00464-017-5831-3","article-title":"Factors affecting operative efficiency and post-operative convalescence in laparoendoscopic single-site (LESS) adrenalectomy","volume":"32","author":"Tsai","year":"2018","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jfma.2018.01.006_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijsu.2015.01.015","article-title":"Recurrence and functional outcomes of partial adrenalectomy: a systematic review and meta-analysis","volume":"16","author":"Nagaraja","year":"2015","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.ju.0000162045.68387.c3","article-title":"Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma","volume":"174","author":"Ishidoya","year":"2005","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000313480206800307","article-title":"Primary hyperaldosteronism in the era of laparoscopic adrenalectomy\/discussion","volume":"68","author":"Rossi","year":"2002","journal-title":"Am Surg"},{"issue":"4","key":"10.1016\/j.jfma.2018.01.006_bib22","first-page":"320","article-title":"Outcome of patients undergoing laparoscopic adrenalectomy for primary hyperaldosteronism","volume":"8","author":"Goh","year":"2004","journal-title":"J Soc Laparoendosc Surg"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/000313480707300218","article-title":"Long-term results of endoscopic adrenalectomy for Conn's syndrome","volume":"73","author":"Gockel","year":"2007","journal-title":"Am Surg"},{"issue":"9","key":"10.1016\/j.jfma.2018.01.006_bib24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1445-2197.2007.04225.x","article-title":"Outcomes of laparoscopic adrenalectomy for hyperladosteronism","volume":"77","author":"Pang","year":"2007","journal-title":"ANZ J Surg"},{"issue":"5","key":"10.1016\/j.jfma.2018.01.006_bib25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00268-008-9513-0","article-title":"Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia","volume":"32","author":"Walz","year":"2008","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.jfma.2018.01.006_bib26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-08-0902","article-title":"Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma","volume":"160","author":"Giacchetti","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.2016152277","article-title":"Aldosterone-producing adenoma in primary aldosteronism: CT-guided radiofrequency ablation\u2014long-term results and recurrence rate","volume":"281","author":"Liu","year":"2016","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiology.209.2.9807561","article-title":"Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases","volume":"209","author":"Goldberg","year":"1998","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jfma.2018.01.006_bib29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/SLA.0b013e318f66936","article-title":"Radiofrequency ablation for benign aldosterone-producing adenoma: a scarless technique to an old disease","volume":"252","author":"Liu","year":"2010","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.jfma.2018.01.006_bib30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2214\/ajr.168.5.9129420","article-title":"Transcatheter arterial ablation of aldosteronomas with high-concentration ethanol: preliminary and long-term results","volume":"168","author":"Inoue","year":"1997","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiol.2272011798","article-title":"Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases","volume":"227","author":"Hokotate","year":"2003","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1530\/eje.0.1320302","article-title":"Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocortical adenoma","volume":"132","author":"Rossi","year":"1995","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1507\/endocrj.47.185","article-title":"CT-guided acetic acid injection therapy for aldosterone-producing adrenocortical adenoma: a preliminary report of three cases","volume":"47","author":"Minowada","year":"2000","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jfma.2012.01.009","article-title":"Recurrence of primary aldosteronism after percutaneous ethanol injection","volume":"111","author":"Chang","year":"2012","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"10.1016\/j.jfma.2018.01.006_bib35","doi-asserted-by":"crossref","first-page":"600","DOI":"10.6061\/clinics\/2016(10)08","article-title":"Long-term results after CT-guided percutaneous ethanol ablation for the treatment of hyperfunctioning adrenal disorders","volume":"71","author":"Frenk","year":"2016","journal-title":"Clinics"},{"issue":"5","key":"10.1016\/j.jfma.2018.01.006_bib36","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jfma.2018.01.006_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneph0151","article-title":"Primary aldosteronism: diagnostic and treatment strategies","volume":"2","author":"Mattsson","year":"2006","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.jfma.2018.01.006_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.jfma.2018.01.006_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jfma.2018.01.006_bib40","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jfma.2018.01.006_bib41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ncpendmet0676","article-title":"Drug insight: eplerenone, a mineralocorticoid-receptor antagonist","volume":"4","author":"McManus","year":"2008","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.jfma.2018.01.006_bib43","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3109\/0886022X.2012.672156","article-title":"Mineralocorticoid receptor antagonist for renal protection","volume":"34","author":"Ma","year":"2012","journal-title":"Ren Fail"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/FJC.0000000000000329","article-title":"Third-generation mineralocorticoid receptor antagonists: why do we need a fourth?","volume":"67","author":"Gomez-Sanchez","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jama.1973.03220010068036","article-title":"Gynecomastia and impotence: complications of spironolactone therapy","volume":"223","author":"Greenblatt","year":"1973","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jfma.2018.01.006_bib46","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1749-6632.1960.tb20077.x","article-title":"Studies on the metabolic effects of spironolactone in man","volume":"88","author":"Hood","year":"1960","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ejhf.444","article-title":"Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease","volume":"18","author":"Bramlage","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10741-005-2345-1","article-title":"Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis","volume":"10","author":"Sica","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jfma.2018.01.006_bib49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2015.07.006","article-title":"Pharmacological treatment of aldosterone excess","volume":"154","author":"Deinum","year":"2015","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0b013e3283599b6a","article-title":"Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension","volume":"31","author":"Colussi","year":"2013","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.jfma.2018.01.006_bib51","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: characterization in\u00a0vivo and in\u00a0vitro","volume":"240","author":"De Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.jfma.2018.01.006_bib53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1977.tb01307.x","article-title":"Amiloride in the treatment of primary hyperaldosteronism and essential hypertension","volume":"7","author":"Kremer","year":"1977","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.1982.9","article-title":"Amiloride in primary hyperaldosteronism","volume":"31","author":"Gritting","year":"1982","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/clpt.1980.42","article-title":"Spironolactone and amiloride in hypertensive patients with and without aldosterone excess","volume":"27","author":"Hoefnagels","year":"1980","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib58","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.ackd.2014.10.003","article-title":"Outcomes of drug-based and surgical treatments for primary aldosteronism","volume":"22","author":"Steichen","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib59","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/EJE-14-0444","article-title":"Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy","volume":"172","author":"Riester","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.jfma.2018.01.006_bib60","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/EJE-13-0263","article-title":"EJE prize 2013: Regulation of aldosterone secretion: from physiology to disease","volume":"168","author":"Beuschlein","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.jfma.2018.01.006_bib61","doi-asserted-by":"crossref","first-page":"E878","DOI":"10.1210\/jc.2010-2723","article-title":"Psychological assessment of primary aldosteronism: a controlled study","volume":"96","author":"Sonino","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jfma.2018.01.006_bib62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000093956","article-title":"Psychological aspects of primary aldosteronism","volume":"75","author":"Sonino","year":"2006","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/15622975.2012.665480","article-title":"Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study","volume":"15","author":"Apostolopoulou","year":"2014","journal-title":"World J Biol Psychiatr"},{"issue":"11","key":"10.1016\/j.jfma.2018.01.006_bib64","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ajh\/hpv047","article-title":"State of the art review: depression, stress, anxiety, and cardiovascular disease","volume":"28","author":"Cohen","year":"2015","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib65","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yhbeh.2008.02.004","article-title":"Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior","volume":"54","author":"Hlavacova","year":"2008","journal-title":"Horm Behav"},{"key":"10.1016\/j.jfma.2018.01.006_bib66","first-page":"21","article-title":"Psychosocial approach to endocrine disease","volume":"vol. 28","author":"Sonino","year":"2007"},{"issue":"4","key":"10.1016\/j.jfma.2018.01.006_bib67","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.2015.18392","article-title":"Screening for depression in adults: US preventive Services Task Force recommendation statement","volume":"315","author":"Siu","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.jfma.2018.01.006_bib68","series-title":"H. L: Management and treatment of anxiety syndromes","first-page":"219","year":"2015"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"Care WTFoMDiP, WFSBP Task Force on Anxiety Disorders O, PTSD: guidelines for the pharmacological treatment of anxiety disorders, obsessive\u2013compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int J Psychiatr Clin Pract"},{"issue":"8","key":"10.1016\/j.jfma.2018.01.006_bib70","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jfma.2018.01.006_bib71","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib72","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn's registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib73","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2011.12.003","article-title":"Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma","volume":"221","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jfma.2018.01.006_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000501029.29956.85","article-title":"OS 35-09 long-term outcome of surgically- and medically-treated patients of the primary aldosteronism prevalence in hypertensives (PAPY) study","volume":"34","author":"Maiolino","year":"2016","journal-title":"J Hypertens"},{"issue":"8","key":"10.1016\/j.jfma.2018.01.006_bib75","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/HJH.0000000000001361","article-title":"Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years","volume":"35","author":"Wu","year":"2017","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.jfma.2018.01.006_bib76","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.3033","article-title":"Risk of fracture in primary aldosteronism: a population-based cohort study","volume":"32","author":"Wu","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib77","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jfma.2018.01.006_bib79","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1210\/jc.2011-0354","article-title":"Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study","volume":"96","author":"Pimenta","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jfma.2018.01.006_bib80","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"7","key":"10.1016\/j.jfma.2018.01.006_bib81","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1210\/jc.2006-0101","article-title":"Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism","volume":"91","author":"Rizzoni","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.jfma.2018.01.006_bib82","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens"},{"issue":"7","key":"10.1016\/j.jfma.2018.01.006_bib83","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension","volume":"25","author":"Holaj","year":"2007","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.jfma.2018.01.006_bib84","doi-asserted-by":"crossref","first-page":"461","DOI":"10.33549\/physiolres.932344","article-title":"Peripheral arterial stiffness in primary aldosteronism","volume":"61","author":"Rosa","year":"2012","journal-title":"Physiol Res"},{"issue":"4","key":"10.1016\/j.jfma.2018.01.006_bib85","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1507\/endocrj.K09E-014","article-title":"Endothelial dysfunction is related to aldosterone excess and raised blood pressure","volume":"56","author":"Tsuchiya","year":"2009","journal-title":"Endocr J"},{"issue":"9","key":"10.1016\/j.jfma.2018.01.006_bib86","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/HJH.0b013e32834a4c75","article-title":"Aldosterone as a modulator of immunity: implications in the organ damage","volume":"29","author":"Herrada","year":"2011","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib87","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cardfail.2005.08.005","article-title":"The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure","volume":"12","author":"Kotlyar","year":"2006","journal-title":"J Card Fail"},{"issue":"9","key":"10.1016\/j.jfma.2018.01.006_bib88","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF03346533","article-title":"Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha","volume":"32","author":"Carvajal","year":"2009","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib89","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"issue":"15\u201316","key":"10.1016\/j.jfma.2018.01.006_bib90","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cca.2011.02.018","article-title":"Kidney impairment in primary aldosteronism","volume":"412","author":"Wu","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.jfma.2018.01.006_bib91","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"1","key":"10.1016\/j.jfma.2018.01.006_bib92","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jfma.2018.01.006_bib93","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664617307751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664617307751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:39:27Z","timestamp":1760539167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664617307751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0929664617307751"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2018.01.006","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted treatment of primary aldosteronism \u2013 The consensus of Taiwan Society of Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}